Files in this item
Harm reduction and abstinence-based models for treatment of substance use disorders during the COVID-19 pandemic : a global perspective
Item metadata
dc.contributor.author | Narasimha, V.L. | |
dc.contributor.author | Butner, J. | |
dc.contributor.author | Hanafi, E. | |
dc.contributor.author | Farokhnia, M. | |
dc.contributor.author | Bhad, R. | |
dc.contributor.author | Chalabianloo, F. | |
dc.contributor.author | Kouimtsidis, C. | |
dc.contributor.author | Baldacchino, A. | |
dc.contributor.author | Arunogiri, S. | |
dc.date.accessioned | 2022-03-16T15:30:03Z | |
dc.date.available | 2022-03-16T15:30:03Z | |
dc.date.issued | 2022-08-30 | |
dc.identifier | 278304297 | |
dc.identifier | cb740d16-00fc-41bd-8a24-86a2a62b5bbd | |
dc.identifier | 85125751862 | |
dc.identifier | 85128494763 | |
dc.identifier.citation | Narasimha , V L , Butner , J , Hanafi , E , Farokhnia , M , Bhad , R , Chalabianloo , F , Kouimtsidis , C , Baldacchino , A & Arunogiri , S 2022 , ' Harm reduction and abstinence-based models for treatment of substance use disorders during the COVID-19 pandemic : a global perspective ' , BJPsych International , vol. 19 , no. 3 , pp. 66-69 . https://doi.org/10.1192/bji.2022.1 | en |
dc.identifier.issn | 2056-4740 | |
dc.identifier.other | RIS: urn:4A60AF7CFE0B9F6E4F08327D9AD22B76 | |
dc.identifier.other | ORCID: /0000-0002-5388-7376/work/110131495 | |
dc.identifier.uri | https://hdl.handle.net/10023/25056 | |
dc.description | Funding: M.F. is an employee of the US Federal Government and is supported by National Institutes of Health (NIH) intramural funding (ZIA-DA000635 and ZIA-AA000218), outside of this research. | en |
dc.description.abstract | The COVID-19 pandemic has significantly affected treatment services for people with substance use disorders (SUDs). Based on the perspectives of service providers from eight countries, we discuss the impact of the pandemic on SUD treatment services. Although many countries quickly adapted in provision of harm reduction services by changes in policy and service delivery, some went into a forced abstinence-based strategy. Similarly, disruption of abstinence-based approaches such as therapeutic communities has been reported. Global awareness is crucial for responsible management of SUDs during the pandemic, and the development of international health policy guidelines is an urgent need in this area. | |
dc.format.extent | 4 | |
dc.format.extent | 304487 | |
dc.language.iso | eng | |
dc.relation.ispartof | BJPsych International | en |
dc.subject | Abstinence | en |
dc.subject | Addiction | en |
dc.subject | COVID-19 | en |
dc.subject | Harm reduction | en |
dc.subject | Substance use | en |
dc.subject | Treatment | en |
dc.subject | BF Psychology | en |
dc.subject | RA0421 Public health. Hygiene. Preventive Medicine | en |
dc.subject | RM Therapeutics. Pharmacology | en |
dc.subject | Psychiatry and Mental health | en |
dc.subject | T-DAS | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | MCC | en |
dc.subject.lcc | BF | en |
dc.subject.lcc | RA0421 | en |
dc.subject.lcc | RM | en |
dc.title | Harm reduction and abstinence-based models for treatment of substance use disorders during the COVID-19 pandemic : a global perspective | en |
dc.type | Journal article | en |
dc.contributor.institution | University of St Andrews. School of Medicine | en |
dc.contributor.institution | University of St Andrews. Centre for Minorities Research (CMR) | en |
dc.contributor.institution | University of St Andrews. Population and Behavioural Science Division | en |
dc.identifier.doi | 10.1192/bji.2022.1 | |
dc.description.status | Peer reviewed | en |
This item appears in the following Collection(s)
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.